Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
Open Access
- 17 November 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (22) , 8662
Abstract
Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system. Nowadays, available therapies for MS can help to manage MS course and symptoms, but new therapeutic approaches are required. Stem cell therapy using mesenchymal stem cells (MSCs) appeared promising in different neurodegenerative conditions, thanks to their beneficial capacities, including the immunomodulation ability, and to their secretome. The secretome is represented by growth factors, cytokines, and extracellular vesicles (EVs) released by MSCs. In this review, we focused on studies performed on in vivo MS models involving the administration of MSCs and on clinical trials evaluating MSCs administration. Experimental models of MS evidenced that MSCs were able to reduce inflammatory cell infiltration and disease score. Moreover, MSCs engineered to express different genes, preconditioned with different compounds, differentiated or in combination with other compounds also exerted beneficial actions in MS models, in some cases also superior to native MSCs. Secretome, both conditioned medium and EVs, also showed protective effects in MS models and appeared promising to develop new approaches. Clinical trials highlighted the safety and feasibility of MSC administration and reported some improvements, but other trials using larger cohorts of patients are needed.Keywords
Funding Information
- Ministero della Salute (-)
This publication has 111 references indexed in Scilit:
- Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune systemBrain, Behavior, and Immunity, 2015
- Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Preinduced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of RatsCell Transplantation, 2015
- Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelinationAnnals of Anatomy - Anatomischer Anzeiger, 2015
- Bone Marrow Mesenchymal Stromal Cells Isolated from Multiple Sclerosis Patients have Distinct Gene Expression Profile and Decreased Suppressive Function Compared with Healthy CounterpartsCell Transplantation, 2015
- Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cells Induces a Switch from Classical to Atypical Symptoms in Experimental Autoimmune EncephalomyelitisStem Cells International, 2015
- Defining the clinical course of multiple sclerosisNeurology, 2014
- Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage ActivationImmunity, 2014
- Mesenchymal stem cells: a new trend for cell therapyActa Pharmacologica Sinica, 2013
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Sex differences in experimental autoimmune encephalomyelitis in multiple murine strainsJournal of Neuroimmunology, 2004